Crinetics Pharmaceuticals...

NASDAQ: CRNX · Real-Time Price · USD
34.20
0.10 (0.29%)
At close: Sep 17, 2025, 3:59 PM
34.20
0.00%
After-hours: Sep 17, 2025, 04:17 PM EDT
0.29%
Bid 34.13
Market Cap 3.22B
Revenue (ttm) 1.39M
Net Income (ttm) -369.83M
EPS (ttm) -4.1
PE Ratio (ttm) -8.34
Forward PE -6.75
Analyst Buy
Dividends n/a
Ask 34.3
Volume 819,061
Avg. Volume (20D) 961,379
Open 34.27
Previous Close 34.10
Day's Range 33.84 - 35.03
52-Week Range 24.10 - 62.53
Beta 0.28
Ex-Dividend Date n/a

About CRNX

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CRNX
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CRNX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
Crinetics Pharmaceuticals Inc. is scheduled to release its earnings on Nov 11, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-3.69%
CRNX stock has given up its prior gain. Crinetics ... Unlock content with Pro Subscription
1 month ago
-3.69%
Crinetics Pharmaceuticals shares are trading higher after the company reported a Q2 revenue beat and announced the Palsonify NDA is on track.